NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Endoluminal Solutions Inc.

Endoluminal Solutions Inc.

Private
OsakaHealthcare & Life Scienceshttps://endoluminalsolutions.com/

Last Round

M&A

Jul 1, 2024

Est. Valuation

$165M

Total Funding Raised

$159.24M

Company Overview

Endoluminal Solutions Inc. is a medical device company that develops innovative, disposable endoscopic systems specialized for gastric cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

disposable gastroscopesingle-use endoscopegastric cancer screeningmedical deviceAI diagnostic supportendoscopygastroenterology techmedical AIclinical diagnostic softwaremedtechdigital pathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Endoluminal Solutions Inc. Comps

Public and private peers based on sector, stage, and business model.

Endoluminal Solutions Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Endoluminal Solutions Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AJul 1, 2024
Series IMay 29, 2019
Series GMay 7, 2014
Series ENov 25, 2009
Series DAug 29, 2007
Series C
Feb 24, 2006

Endoluminal Solutions Inc. Investors

Notable investors and investment history

Endoluminal Solutions Inc. investors
InvestorRounds
Radius VenturesSeries G, Series I
Evidity Health CapitalSeries I
Chicago Growth PartnersSeries D, Series G, Series I, Series C
MPM BioImpactSeries C, Series D, Series A
SightLine PartnersSeries I
Advanced Technology VenturesSeries C, Series D, Series G, Series E, Series I, Series A
Canaan PartnersSeries G, Series I

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2003

    $737K round with participation from Advanced Technology Ventures and MPM BioImpact.

Endoluminal Solutions Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Endoluminal Solutions Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Endoluminal Solutions Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersOsaka
Year Founded2025
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.